Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CODA: Antibiotics vs Appendectomy for Appendicitis
NCT02800785Completed
- Sponsor
- University of Washington
- Start
- May 2016
- Primary completion
- Mar 2020
- Modality
- Implantable Devices, Reversible Covalent Inhibitors, Transdermal Patches
- Countries
- 1
01
Overview
Randomised, open-label trial of cefoxitin, ertapenem, moxifloxacin, tigecycline, ticarcillin plus clavulanic acid and 7 more in appendicitis (2 arms), sponsored by University of Washington. Primary endpoint: Patient-reported Quality of Life as Measured by EuroQol at 4 weeks. Started May 2016; status: completed.
02
Drugs
cefoxitinertapenemmoxifloxacintigecyclineticarcillin plus clavulanic acid
03
Conditions
appendicitis
Beyond the preview
Go deeper on NCT02800785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02800785.